Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Oct 1;6(4):263-272.
doi: 10.1093/ehjqcco/qcaa040.

Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions

Fatima Ali-Ahmed  1 , Karen Pieper  1 , Rebecca North  2 , Larry A Allen  3 , Paul S Chan  4 , Michael D Ezekowitz  5 , Gregg C Fonarow  6 , James V Freeman  7 , Alan S Go  8 , Bernard J Gersh  9 , Peter R Kowey  5   10 , Kenneth W Mahaffey  11 , Gerald V Naccarelli  12 , Sean D Pokorney  1 , James A Reiffel  13 , Daniel E Singer  14 , Benjamin A Steinberg  15 , Eric D Peterson  1 , Jonathan P Piccini  1 , Emily C O'Brien  1
Affiliations
Multicenter Study

Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions

Fatima Ali-Ahmed et al. Eur Heart J Qual Care Clin Outcomes. .

Abstract

Aims: To determine the extent of shared decision-making (SDM), during selection of oral anticoagulant (OAC) and rhythm control treatments, in patients with newly diagnosed atrial fibrillation (AF).

Methods and results: We evaluated survey data from 1006 patients with new-onset AF enrolled at 56 US sites participating in the SATELLITE substudy of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT II). Patients completed surveys at enrolment and at 6-month follow-up. Patients were asked about who made their AF treatment decisions. Shared decision-making was classified as one that the patient felt was an autonomous decision or a shared decision with their healthcare provider (HCP). Approximately half of patients reported that their OAC treatment decisions were made entirely by their HCP. Compared with those reporting no SDM, patients reporting SDM for OAC were more often female (47.2% vs. 38.4%), while patients reporting SDM for rhythm control were more often male (62.2% vs. 57.6%). The most important factors cited by patients during decision-making for OAC were reducing stroke and bleeding risk, and their HCP's recommendations. After adjustment, patients with self-reported understanding of OAC, and rhythm control options, had higher odds of having participated in SDM [odds ratio (OR) 2.54, confidence interval (CI): 1.75-3.68 and OR 2.36, CI: 1.50-3.71, both P ≤ 0.001, respectively].

Conclusion: Shared decision-making is not widely implemented in contemporary AF practice. Patient understanding about available therapeutic options is associated with a more than a two-fold higher likelihood of SDM, and may be a potential target for future interventions.

Keywords: Atrial Fibrillation; Patient-reported involvement in treatment decisions; Quality of care; Shared decision-making; Stroke prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Decision-making for blood thinners (upper panel) and rhythm control (lower panel), at baseline and 6-month follow-up, by degree of self-participation.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chamberlain AM, Gersh BJ, Alonso A, Chen LY, Berardi C, Manemann SM et al. Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med 2015;128:260–267.e1. - PMC - PubMed
    1. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:154–162. - PMC - PubMed
    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001;285:2370. - PubMed
    1. Plitt A, McGuire DK, Giugliano RP. Atrial fibrillation, type 2 diabetes, and non–vitamin K antagonist oral anticoagulants. JAMA Cardiol 2017;2:442. - PubMed
    1. Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation. Circ J 2009;73:242–248. - PubMed

Publication types